Croda International Plc Price Target Lowered to GBX 2,248 at Numis Securities Ltd (CRDA)
Research analysts at Numis Securities Ltd dropped their price objective on shares of Croda International Plc (LON:CRDA) from GBX 2,554 ($43.46) to GBX 2,248 ($38.26) in a report released on Wednesday. The firm currently has a “hold” rating on the stock. Numis Securities Ltd’s target price would indicate a potential upside of 2.74% from the stock’s previous close.
Croda International Plc (LON:CRDA) traded down 3.75% during mid-day trading on Wednesday, hitting GBX 2106.00. 937,957 shares of the company’s stock traded hands. Croda International Plc has a 52 week low of GBX 2095.00 and a 52 week high of GBX 2761.00. The stock has a 50-day moving average of GBX 2504.42 and a 200-day moving average of GBX 2469.61. The company’s market cap is £2.837 billion.
CRDA has been the subject of a number of other recent research reports. Analysts at Citigroup Inc. cut their price target on shares of Croda International Plc from GBX 2,100 ($35.74) to GBX 1,900 ($32.33) in a research note on Wednesday. They now have a “sell” rating on the stock. Separately, analysts at Liberum Capital downgraded shares of Croda International Plc to a “sell” rating in a research note on Tuesday. They now have a GBX 2,000 ($34.04) price target on the stock, down previously from GBX 2,500 ($42.55). Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Croda International Plc in a research note on Tuesday. They now have a GBX 2,800 ($47.65) price target on the stock. Three analysts have rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of GBX 2,578.71 ($43.89).
Croda International Plc is a marketing and technology company that produces and sells speciality chemicals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.